S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Deep Track Capital/Q4 2023

Deep Track Capital

Period: Q4 2023 Β· Filed: 2024-02-14
View on SEC EDGAR β†—
AUM
$2.99B
Total portfolio value
Positions
60
Reported securities
Top Holding
INSM
5.5% $165.8M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-02-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
INSMINSMED INC$165.8M5.54%$29.94$111.60+272.8%
5.5%
SWTXSPRINGWORKS THERAPEUTICS INC$148.3M4.95%β€”β€”
5.0%
ITCIINTRA-CELLULAR THERAPIES INC$143.2M4.78%β€”β€”
4.8%
GHGUARDANT HEALTH INC$135.3M4.52%$26.51$167.98+533.6%
4.5%
ARGXARGENX SE$114.1M3.81%$381.00$939.68+146.6%
3.8%
CYTKCALLCYTOKINETICS INC$112.5M3.76%$84.12$86.49+2.8%
3.8%
ALKSALKERMES PLC$111.0M3.71%$28.62$54.58+90.7%
3.7%
PLRXPLIANT THERAPEUTICS INC$104.1M3.48%$17.96$1.17-93.5%
3.5%
DVAXDYNAVAX TECHNOLOGIES CORP$99.2M3.31%β€”β€”
3.3%
AXSMAXSOME THERAPEUTICS INC$79.6M2.66%$77.06$244.31+217.0%
2.7%
VRDNVIRIDIAN THERAPEUTICS INC$79.1M2.64%$22.35$19.40-13.2%
2.6%
AUTLAUTOLUS THERAPEUTICS PLC$76.4M2.55%$6.84$1.58-76.9%
2.5%
PACBPACIFIC BIOSCIENCES CALIF IN$68.7M2.29%$9.59$1.68-82.5%
2.3%
NTLAINTELLIA THERAPEUTICS INC$68.6M2.29%$30.82$17.56-43.0%
2.3%
TVTXTRAVERE THERAPEUTICS INC$66.3M2.21%$9.56$56.92+495.4%
2.2%
APGEAPOGEE THERAPEUTICS INC$64.9M2.17%$28.51$132.91+366.2%
2.2%
VRNAVERONA PHARMA PLC$63.4M2.12%β€”β€”
2.1%
IONSIONIS PHARMACEUTICALS INC$63.2M2.11%$52.87$81.80+54.7%
2.1%
BCYCBICYCLE THERAPEUTICS PLC$63.1M2.11%$18.44$4.35-76.4%
2.1%
GERNGERON CORP$62.4M2.08%$2.14$1.36-36.5%
2.1%
EDITEDITAS MEDICINE INC$55.4M1.85%$9.98$3.65-63.4%
1.9%
AMAMAMBRX BIOPHARMA INC$52.8M1.76%β€”β€”
1.8%
SRPTSAREPTA THERAPEUTICS INC$48.2M1.61%$96.21$19.28-80.0%
1.6%
TRMLTOURMALINE BIO INC$47.5M1.59%β€”β€”
1.6%
HLVXHILLEVAX INC$46.5M1.55%β€”β€”
1.6%
FDMT4D MOLECULAR THERAPEUTICS IN$46.3M1.55%$21.25$13.00-38.8%
1.6%
ABVXABIVAX SA$46.0M1.54%$10.80$144.65+1239.3%
1.5%
RAPTRAPT THERAPEUTICS INC$44.6M1.49%β€”β€”
1.5%
ANABANAPTYSBIO INC$43.6M1.46%$14.47$63.42+338.3%
1.5%
IMVTIMMUNOVANT INC$42.1M1.41%$41.39$38.79-6.3%
1.4%

Quarter-on-Quarter Activity

Q4 2023 vs. Q3 2023

New Positions (8)

TickerIssuerNotionalSince Filing
ARGXARGENX SE$114.1M+146.6%
CYTKCYTOKINETICS INC$112.5M+2.8%
AMAMAMBRX BIOPHARMA INC$52.8M
SRPTSAREPTA THERAPEUTICS INC$48.2M-80.0%
TRMLTOURMALINE BIO INC$47.5M
ABVXABIVAX SA$46.0M+1239.3%
SYRESPYRE THERAPEUTICS INC$42.0M
OCULOCULAR THERAPEUTIX INC$41.2M

Exited Positions (8)

TickerIssuerNotional
NVCRNOVOCURE LTD$40.4M
NBIXNEUROCRINE BIOSCIENCES INC$33.8M
BEAMBEAM THERAPEUTICS INC$24.4M
AMLXAMYLYX PHARMACEUTICALS INC$23.1M
BNTXBIONTECH SE$21.7M
MRNAMODERNA INC$20.7M
PNTPOINT BIOPHARMA GLOBAL INC$18.6M
MORFMORPHIC HLDG INC$10.8M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
SRRKSCHOLAR ROCK HLDG CORP$16.5M+185.9%
AGIOAGIOS PHARMACEUTICALS INC$13.2M+151.7%
PRTAPUTPROTHENA CORP PLC$6.1M+100.0%
ANABANAPTYSBIO INC$19.5M+51.4%+338.3%
ANIPANI PHARMACEUTICALS INC$9.9M+50.0%
GHGUARDANT HEALTH INC$15.2M+23.5%+533.6%
VRDNVIRIDIAN THERAPEUTICS INC$33.6M+22.6%-13.2%
RAPTRAPT THERAPEUTICS INC$19.6M+19.6%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
JAZZJAZZ PHARMACEUTICALS PLC$-141.4M-95.8%
GPCRSTRUCTURE THERAPEUTICS INC$-84.3M-84.3%
IMVTIMMUNOVANT INC$-65.3M-64.3%-6.3%
IONSIONIS PHARMACEUTICALS INC$-65.4M-55.9%+54.7%
RLMDRELMADA THERAPEUTICS INC$-0.1M-28.0%
ITCIINTRA-CELLULAR THERAPIES INC$7.8M-23.1%
EDITEDITAS MEDICINE INC$0.1M-22.9%-63.4%
AUTLAUTOLUS THERAPEUTICS PLC$41.5M-20.9%-76.9%
← Back to Hedge Funds